Kolexia
Jourdan Jean-Pierre
Pharmacien
Centre Hospitalier de Vire
Viré, France
53 Activités
714 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie d'Alzheimer Maladies neurodégénératives Urgences Peptides bêta-amyloïdes Agrégats de protéines Amyloïde Antioxydants Bexarotène Antagonistes cholinergiques

Industries

Novartis
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs.
International journal of molecular sciences   30 novembre 2023
Implementation of clinical medication review in a geriatric ward to reduce potentially inappropriate prescriptions among older adults.
European journal of clinical pharmacology   19 août 2023
FRENCH versus ESI: comparison between two nurse triage emergency scales with referent scenarios.
BMC emergency medicine   12 décembre 2022
Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease.
British journal of clinical pharmacology   23 décembre 2020
Desirable drug-drug interactions or when a matter of concern becomes a renewed therapeutic strategy.
Drug discovery today   27 novembre 2020
Noncellular screening for the discovery of protein-protein interaction modulators.
Drug discovery today   16 juillet 2020
Drug repositioning: a brief overview.
The Journal of pharmacy and pharmacology   17 avril 2020
Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.
International journal of clinical pharmacy   26 octobre 2018
Benzylphenylpyrrolizinones with Anti-amyloid and Radical Scavenging Effects, Potentially Useful in Alzheimer's Disease Treatment.
ChemMedChem   12 avril 2017
Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment.
European journal of medicinal chemistry   12 mars 2016